Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - CHAMPIONS ONCOLOGY, INC. | c09238exv31w1.htm |
| EX-31.2 - EXHIBIT 31.2 - CHAMPIONS ONCOLOGY, INC. | c09238exv31w2.htm |
| 10-Q - FORM 10-Q - CHAMPIONS ONCOLOGY, INC. | c09238e10vq.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Champions Biotechnology, Inc. (the “Company”) on
Form 10-Q for the period ending October 31, 2010 as filed with the Securities and Exchange
Commission on the date hereof (the “Report”), each of the undersigned, in the capacities and on the
dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that to their knowledge:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. |
| Date: December 13, 2010 | /s/ Joel Ackerman | |||
| Joel Ackerman | ||||
| Chief Executive Officer | ||||
| /s/ Mark R. Schonau | ||||
| Mark R. Schonau | ||||
| Chief Financial Officer | ||||